Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Clinical Studies

Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon

Abstract

Background

Despite a reduction of both incidence and mortality from CRC, recent studies have shown an increase in the incidence of early-onset CRC (EO-CRC). Data on this setting are limited. The aim of our study was to evaluate the clinical and molecular profiles of metastatic EO-CRC patients in order to identify differences compared to a late-onset CRC (LO-CRC) control group.

Methods

We retrospectively collected data from 1272 metastatic colorectal cancers from 5 different Italian Institutions. The main objective was to the evaluate clinical outcome for EO-CRC patients in comparison to patients included in the control group.

Results

In the overall population, mOS was 34,7 in EO-CRC pts vs 43,0 months (mo) (p < 0,0001). In the RAS/BRAF mutated subgroup mOS in EO-CRC pts was 30,3 vs 34,0 mo (p = 0,0156). In RAS/BRAF wild-type EO-CRC mOS was 43,0 vs 50,0 mo (p = 0,0290). mPFS was 11,0 in EO-CRC pts vs 14,0 mo (p < 0,0001).

Conclusion

Findings indicate a general worse prognosis for patients with early-onset colorectal cancer compared to late-onset patients. Interestingly this seems to occur regardless of the molecular status. These observations might have a considerable impact on clinical practice and research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3: Kaplan–Meier curves for EO-CRC and LO-CRC, overall population.
Fig. 4: Kaplan–Meier curves for EO-CRC and LO-CRC, RAS and BRAF wild-type population.
Fig. 5: Kaplan–Meier curves for EO-CRC and LO-CRC, RAS/BRAS mutated population.
Fig. 6: Kaplan–Meier curves for EO-CRC and LO-CRC, BRAF V600E mutated population.

Similar content being viewed by others

Data availability

Datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. https://doi.org/10.3322/caac.21708.

    Article  PubMed  Google Scholar 

  3. Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, et al. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol. 2021;18:230–43. https://doi.org/10.1038/s41571-020-00445-1.

    Article  PubMed  Google Scholar 

  4. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4:511–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109:djw322 https://doi.org/10.1093/jnci/djw322.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150:17–22. https://doi.org/10.1001/jamasurg.2014.1756.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Feletto E, Yu XQ, Lew JB, St John DJB, Jenkins MA, Macrae FA, et al. Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: analysis of data on over 375,000 cases. Cancer Epidemiol Biomarkers Prev. 2019;28:83–90. https://doi.org/10.1158/1055-9965.EPI-18-0523.

    Article  PubMed  Google Scholar 

  8. Brenner DR, Ruan Y, Shaw E, De P, Heitman SJ, Hilsden RJ. Increasing colorectal cancer incidence trends among younger adults in Canada. Prev Med. 2017;105:345–9. https://doi.org/10.1016/j.ypmed.2017.10.007.

    Article  PubMed  Google Scholar 

  9. Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer. 2010;126:721–32. https://doi.org/10.1002/ijc.24839.

    Article  CAS  PubMed  Google Scholar 

  10. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4:511–8. https://doi.org/10.1016/S2468-1253(19)30147-5.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145–64. https://doi.org/10.3322/caac.21601.

    Article  PubMed  Google Scholar 

  12. REACCT Collaborative, Zaborowski AM, Abdile A, Adamina M, Aigner F, d’Allens L, Allmer C, et al. Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg. 2021;156:865–74. https://doi.org/10.1001/jamasurg.2021.2380.

  13. Bhandari A, Woodhouse M, Gupta S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. J Investig Med. 2017;65:311–5. https://doi.org/10.1136/jim-2016-000229.

    Article  PubMed  Google Scholar 

  14. Chen FW, Sundaram V, Chew TA, Ladabaum U. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol. 2017;15:728–37.e3. https://doi.org/10.1016/j.cgh.2016.10.038.

    Article  PubMed  Google Scholar 

  15. Sandhu GS, Anders R, Walde A, Leal AD, Teng King G, Leong S, et al. High incidence of advanced stage cancer and prolonged rectal bleeding history before diagnosis in young-onset patients with colorectal cancer. J Clin Oncol. 2019;37:3576

  16. Yarden RI, Newcomer KL; Never Too Young Advisory Board, Colorectal Cancer Alliance. Young onset colorectal cancer patients are diagnosed with advanced disease after multiple misdiagnoses. 2019 AACR Annual Meeting, Atlanta, GA; 2019.

  17. Liu PH, Wu K, Ng K, Zauber AG, Nguyen LH, Song M, et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 2019;5:37–44. https://doi.org/10.1001/jamaoncol.2018.4280.

    Article  PubMed  Google Scholar 

  18. Jensen BW, Bjerregaard LG, Ängquist L, Gögenur I, Renehan AG, Osler M, et al. Change in weight status from childhood to early adulthood and late adulthood risk of colon cancer in men: a population-based cohort study. Int J Obes. 2018;42:1797–803. https://doi.org/10.1038/s41366-018-0109-y.

    Article  Google Scholar 

  19. Zhang J, Haines C, Watson AJM, Hart AR, Platt MJ, Pardoll DM, et al. Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut. 2019;68:1971–8. https://doi.org/10.1136/gutjnl-2019-318593.

    Article  CAS  PubMed  Google Scholar 

  20. Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, et al. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol. 2021;18:230–43. https://doi.org/10.1038/s41571-020-00445-1.

    Article  PubMed  Google Scholar 

  21. Eng C, Jácome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 2022;23:e116–28. https://doi.org/10.1016/S1470-2045(21)00588-X.

    Article  PubMed  Google Scholar 

  22. Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122:929–34. https://doi.org/10.1002/cncr.29716.

    Article  PubMed  Google Scholar 

  23. Teng A, Lee DY, Cai J, Patel SS, Bilchik AJ, Goldfarb MR. Patterns and outcomes of colorectal cancer in adolescents and young adults. J Surg Res. 2016;205:19–27. https://doi.org/10.1016/j.jss.2016.05.036.

    Article  PubMed  Google Scholar 

  24. Georgiou A, Khakoo S, Edwards P, Minchom A, Kouvelakis K, Kalaitzaki E, et al. Outcomes of patients with early onset colorectal cancer treated in a UK Specialist Cancer Center. Cancers. 2019;11:1558. https://doi.org/10.3390/cancers11101558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, Wang SM. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg. 2003;90:205–14. https://doi.org/10.1002/bjs.4015.

    Article  CAS  PubMed  Google Scholar 

  26. Chang DT, Pai RK, Rybicki LA, Dimaio MA, Limaye M, Jayachandran P, et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol. 2012;25:1128–39. https://doi.org/10.1038/modpathol.2012.61.

    Article  PubMed  Google Scholar 

  27. You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012;172:287–9. https://doi.org/10.1001/archinternmed.2011.602.

    Article  PubMed  Google Scholar 

  28. Cercek A, Chatila WK, Yaeger R, Walch H, Fernandes GDS, Krishnan A, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst. 2021;113:1683–92. https://doi.org/10.1093/jnci/djab124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Sinicrope FA. Increasing incidence of early-onset colorectal cancer. N Engl J Med. 2022;386:1547–58. https://doi.org/10.1056/NEJMra2200869.

    Article  CAS  PubMed  Google Scholar 

  30. Kirzin S, Marisa L, Guimbaud R, De Reynies A, Legrain M, Laurent-Puig P, et al. Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. PLoS ONE. 2014;9:e103159. https://doi.org/10.1371/journal.pone.0103159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lieu CH, Golemis EA, Serebriiskii IG, Newberg J, Hemmerich A, Connelly C, et al. Comprehensive genomic landscapes in early and later onset colorectal cancer. Clin Cancer Res. 2019;25:5852–8. https://doi.org/10.1158/1078-0432.CCR-19-0899.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Lieu CH, Renfro LA, de Gramont A, Meyers JP, Maughan TS, Seymour MT, et al. Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program. J Clin Oncol. 2014;32:2975–84. https://doi.org/10.1200/JCO.2013.54.9329.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116:4354–9. https://doi.org/10.1002/cncr.25432.

    Article  PubMed  Google Scholar 

  34. Glover M, Mansoor E, Panhwar M, Parasa S, Cooper GS. Epidemiology of colorectal cancer in average risk adults 20-39 years of age: a population-based national study. Dig Dis Sci. 2019;64:3602–9. https://doi.org/10.1007/s10620-019-05690-8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kneuertz PJ, Chang GJ, Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015;150:402–9. https://doi.org/10.1001/jamasurg.2014.3572.

    Article  CAS  PubMed  Google Scholar 

  36. Saraste D, Järås J, Martling A. Population-based analysis of outcomes with early-age colorectal cancer. Br J Surg. 2020;107:301–9. https://doi.org/10.1002/bjs.11333.

    Article  CAS  PubMed  Google Scholar 

  37. Ben-Ishay O, Brauner E, Peled Z, Othman A, Person B, Kluger Y. Diagnosis of colon cancer differs in younger versus older patients despite similar complaints. Isr Med Assoc J. 2013;15:284–7.

    PubMed  Google Scholar 

  38. Dozois EJ, Boardman LA, Suwanthanma W, Limburg PJ, Cima RR, Bakken JL, et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine. 2008;87:259–3. https://doi.org/10.1097/MD.0b013e3181881354.

    Article  PubMed  Google Scholar 

  39. Tsilimigras DI, Ntanasis-Stathopoulos I, Bagante F, Moris D, Cloyd J, Spartalis E, et al. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: a systematic review of the current evidence. Surg Oncol. 2018;27:280–8. https://doi.org/10.1016/j.suronc.2018.05.012.

    Article  PubMed  Google Scholar 

  40. Rhaiem R, Duramé A, Primavesi F, Dorcaratto D, Syn N, Rodríguez ÁH, et al. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: should surgical strategy be influenced by tumor biology? Surgery. 2024;176:124–33. https://doi.org/10.1016/j.surg.2024.02.008.

    Article  PubMed  Google Scholar 

  41. Blanke CD, Bot BM, Thomas DM, Bleyer A, Kohne CH, Seymour MT, et al. Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials. J Clin Oncol. 2011;29:2781–6. https://doi.org/10.1200/JCO.2010.33.5281.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Chung YF, Eu KW, Machin D, Ho JM, Nyam DC, Leong AF, et al. Young age is not a poor prognostic marker in colorectal cancer. Br J Surg. 1998;85:1255–9. https://doi.org/10.1046/j.1365-2168.1998.00805.x.

    Article  CAS  PubMed  Google Scholar 

  43. Schellerer VS, Merkel S, Schumann SC, Schlabrakowski A, Förtsch T, Schildberg C, et al. Despite aggressive histopathology survival is not impaired in young patients with colorectal cancer : CRC in patients under 50 years of age. Int J Colorectal Dis. 2012;27:71–9. https://doi.org/10.1007/s00384-011-1291-8.

    Article  PubMed  Google Scholar 

  44. McMillan DC, McArdle CS. The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up. Br J Cancer. 2009;101:557–60. https://doi.org/10.1038/sj.bjc.6605222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sanford SD, Zhao F, Salsman JM, Chang VT, Wagner LI, Fisch MJ. Symptom burden among young adults with breast or colorectal cancer. Cancer. 2014;120:2255–63. https://doi.org/10.1002/cncr.28297.

    Article  PubMed  Google Scholar 

  46. Goldvaser H, Purim O, Kundel Y, Shepshelovich D, Shochat T, Shemesh-Bar L, et al. Colorectal cancer in young patients: is it a distinct clinical entity? Int J Clin Oncol. 2016;21:684–95. https://doi.org/10.1007/s10147-015-0935-z.

    Article  CAS  PubMed  Google Scholar 

  47. Vatandoust S, Price TJ, Ullah S, Roy AC, Beeke C, Young JP, et al. Metastatic colorectal cancer in young adults: a study from the South Australian population-based registry. Clin Colorectal Cancer. 2016;15:32–6. https://doi.org/10.1016/j.clcc.2015.07.005.

    Article  PubMed  Google Scholar 

  48. Wang MJ, Ping J, Li Y, Adell G, Arbman G, Nodin B, et al. The prognostic factors and multiple biomarkers in young patients with colorectal cancer. Sci Rep. 2015;5:10645 https://doi.org/10.1038/srep10645.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Rodriguez L, Brennan K, Karim S, Nanji S, Patel SV, Booth CM. Disease characteristics, clinical management, and outcomes of young patients with colon cancer: a population-based study. Clin Colorectal Cancer. 2018;17:e651–61. https://doi.org/10.1016/j.clcc.2018.06.007.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Andrea Pretta: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data Curation, Writing - Original Draft, Writing - Review & Editing, Visualization. Pina Ziranu: Resources, Data Curation, Formal analysis, Writing - Original Draft, Writing - Review & Editing. Eleonora Perissinotto: Resources, Data Curation. Filippo Ghelardi: Resources, Data Curation. Federica Marmorino: Resources, Data Curation. Riccardo Giampieri: Resources, Data Curation, Formal analysis, Writing - Original Draft, Writing - Review & Editing. Mariangela Puci: Data Curation, Formal analysis. Maria Caterina De Grandis: Resources, Data Curation. Eleonora Lai: Resources. Vincenzo Nasca: Resources, Data Curation. Paolo Ciracì: Resources, Data Curation. Marco Puzzoni: Resources. Krisida Cerma: Resources. Data Curation. Carolina Sciortino: Resources, Data Curation. Ada Taravella: Resources, Data Curation. Gianluca Pretta: Writing - Review & Editing. Lorenzo Giuliani: Resources, Data Curation. Camilla Damonte: Resources, Data Curation. Valeria Pusceddu: Resources, Data Curation. Giovanni Sotgiu: Data Curation, Formal analysis. Rossana Berardi: Resources. Sara Lonardi: Resources, Data Curation. Francesca Bergamo: Resources, Data Curation. Filippo Pietrantonio: Resources, Data Curation. Chiara Cremolini: Resources, Data Curation. Mario Scartozzi: Methodology, Validation, Formal analysis, Resources, Data Curation, Writing - Original Draft, Writing - Review & Editing.

Corresponding author

Correspondence to Andrea Pretta.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

Ethics Committee approval was obtained for the study (Protocol number 2020/10912 – code: EMIBIOCCOR) from Cagliari Indipendent Ethics Committee and written informed consent was obtained from all participants for their tissues to be utilized for this work. This study was performed in accordance with the study protocol, the ethical principles stated in the Declaration of Helsinki as well as those indicated in the International Conference on Harmonization (ICH) Note for Guidance on Good Clinical Practice (GCP; ICH E6, 1995), and all applicable regulatory requirements.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pretta, A., Ziranu, P., Perissinotto, E. et al. Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon. Br J Cancer 132, 188–194 (2025). https://doi.org/10.1038/s41416-024-02902-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41416-024-02902-5

Search

Quick links